- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 31 Aug 22 424B4 Prospectus supplement with pricing info
- 30 Aug 22 EFFECT Notice of effectiveness
- 25 Aug 22 S-1/A IPO registration (amended)
- 25 Aug 22 S-1/A IPO registration (amended)
- 23 Aug 22 S-1/A IPO registration (amended)
- 18 Aug 22 S-1/A IPO registration (amended)
- 12 Jul 22 S-1/A IPO registration (amended)
-
23 Jun 22 S-1/A IPO registration (amended)
- 3 Jun 22 S-1 IPO registration
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors of
Shuttle Pharmaceuticals Holdings, Inc. Limited
We consent to the inclusion in the Amendment No. 1 to the Form S-1 Registration Statement of Shuttle Pharmaceuticals Holdings, Inc. (File No. 333-265429) of our report dated June 3, 2022 (except for the effects on the financial statements of the restatement described in Note 9, as to which the date is June 23, 2022), relating to our audit of the balance sheets as of December 31, 2021 and 2020, and statements of operations, stockholders’ equity and cash flows for the years ended December 31, 2021 and 2020.
We also consent to the reference to us under the caption “Experts” in the Registration Statement.
/s/ BF Borgers CPA PC
Certified Public Accountants
Lakewood, Colorado
June 3, 2022, except for the effects on the financial statements of the restatement described in Note 9, as to which the date is June 23, 2022